Articles

The US Food and Drug Administration has accepted a new drug application by Sanofi-Aventis and Pfizer of the United States for Exubera, a dry powder form of insulin that is inhaled into the lungs prior to eating.

Rosiglitazone therapy significantly improved myocardial glucose uptake in type 2 diabetic patients with ischemic coronary artery disease.

Physicians are not aware of the details regarding what new things Medicare is covering

Findings from a study suggest that primary beta-cell dysfunction plays a key role in the pathogenesis of low birth weight (LBW)-associated type 2 diabetes.

Hospital costs for patients with multiple stays averaged $23,100 and women with diabetes were two to four times as likely to be hospitalized for cardiovascular disease as women who did not have diabetes.

Increased Risk for Peripheral Arterial Disease Mortality in Patients With Diabetes Persons with both peripheral arterial disease and diabetes had an adjusted risk of death greater than two-fold that for persons with peripheral arterial disease alone. Patients need to be monitored more often for PAD.

26 percent of nursing home residents have diabetes.

Study Shows Diabetic Women Can’t Rely on Diet Alone.

New research indicates that the The Diabetes Prevention Program (DPP) approach is cost-effective, in delaying or preventing the development of Type 2 diabetes, involving lifestyle and metformin interventions.

Advocates say it will lead to better care; critics say it is a violation of privacy